Drug Development Industry, May 2015 Market Reports from Top Publishers

You might be interested in: Drug, Cloud Computing, Pharmaceutical, Respiratory Treatment, Antidepressant, Oncology, Epilepsy, Biosimilar, Vaccine, Biomarker, Clinical Trial, Ophthalmology, Hormone, Anti-infective, Antibody, Diagnostics, Monoclonal Antibody, Therapeutics, Biosimilars, Diagnostic Test.


 
1-10 of 13 reports for Drug Development

Purchase Reports From Reputable Market Research Publishers

Pediatric drug development - Regulatory challenges and commercial opportunities, CBR Pharma Insights

Pediatric drug development - Regulatory challenges and commercial opportunities, CBR Pharma Insights

  • $ 2 995
  • Industry report
  • July 2014
  • by CBR Pharma Insights

Although pediatrics represent around two-fifths of the global population the market for pediatric medicines remains relatively small (accounting for

Global Alliance for TB Drug Development - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Global Alliance for TB Drug Development - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • March 2015
  • by Global Data

Summary Global Alliance for TB Drug Development (TB Alliance) is a pharmaceutical company. The company discovers and develops drugs to treat tuberculosis. Its products include natural products, isoniazid, ...

Nanoparticles in Biotechnology, Drug Development and Drug Delivery

Nanoparticles in Biotechnology, Drug Development and Drug Delivery

  • $ 6 650
  • Industry report
  • August 2014
  • by BCC Research

This BCC Research report provides detailed product analyses within health and wellness subsegments to overall industry trends in order to quantify and qualify the market for drug products for treating ...

Pediatric drug development - Regulatory challenges and commercial opportunities

Pediatric drug development - Regulatory challenges and commercial opportunities

  • $ 2 995
  • Industry report
  • July 2014
  • by GBI Research

Although pediatrics represent around two-fifths of the global population the market for pediatric medicines remains relatively small (accounting for

Adaptive Licensing - A Holistic Approach to Drug Development and Regulation

Adaptive Licensing - A Holistic Approach to Drug Development and Regulation

  • $ 2 995
  • Industry report
  • July 2014
  • by GBI Research

Adaptive Licensing (AL) is a flexible approach to drug development and regulation, with two live pilot schemes accepted by the European Medicines Agency (EMA). The system acknowledges that levels of uncertainty ...

Adaptive Licensing - A Holistic Approach to Drug Development and Regulation, CBR Pharma Insights

Adaptive Licensing - A Holistic Approach to Drug Development and Regulation, CBR Pharma Insights

  • $ 2 995
  • Industry report
  • July 2014
  • by CBR Pharma Insights

Adaptive Licensing (AL) is a flexible approach to drug development and regulation, with two live pilot schemes accepted by the European Medicines Agency (EMA). The system acknowledges that levels of uncertainty ...

A Global Product and Pipeline Analysis of Antiretroviral Drug Development for the Treatment of HIV/AIDS

A Global Product and Pipeline Analysis of Antiretroviral Drug Development for the Treatment of HIV/AIDS

  • $ 4 000
  • Industry report
  • July 2014
  • by Frost & Sullivan

Antiretroviral Combinations Continue to Transform the Treatment Landscape This research service focuses on antiviral/antiretroviral therapeutics for the treatment of HIV/AIDS. A product and pipeline assessment ...

Cell Culture Market by Equipment (Bioreactor, Incubator, Centrifuge), by Reagent (Media, Sera, Growth Factors, Serum Free Media), by Application (Cancer Research, Gene Therapy, Drug Development, Vaccine Production, Toxicity Testing) - Global Forecast to 2

Cell Culture Market by Equipment (Bioreactor, Incubator, Centrifuge), by Reagent (Media, Sera, Growth Factors, Serum Free Media), by Application (Cancer Research, Gene Therapy, Drug Development, Vaccine Production, Toxicity Testing) - Global Forecast to 2

  • $ 4 650
  • Industry report
  • July 2014
  • by MarketsandMarkets

The report segments the cell culture market into two distinct market segments, namely, the cell culture equipment market and the cell culture media, sera, and reagents market. The segments of the cell ...

Translational Drug Development - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Translational Drug Development - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary Translational Drug Development (TD2) (TGen) is a drug development service company. The company provides oncology treatments to cancer patients. Its services include preclinical services, clinical ...

Biomarkers Market - ([Discovery Technologies - Proteomics, Genomics, Imaging, Bioinformatics], Validation Services, Applications [drug development, personalized medicine], Diseases [Oncology, Cardiology, Neurology]) - Global Trends & Forecasts (2013 – 201

Biomarkers Market - ([Discovery Technologies - Proteomics, Genomics, Imaging, Bioinformatics], Validation Services, Applications [drug development, personalized medicine], Diseases [Oncology, Cardiology, Neurology]) - Global Trends & Forecasts (2013 – 201

  • $ 4 650
  • Industry report
  • September 2013
  • by MarketsandMarkets

Biomarkers Market - ([Discovery Technologies - Proteomics, Genomics, Imaging, Bioinformatics], Validation Services, Applications [drug development, personalized medicine], Diseases [Oncology, Cardiology, ...

About 11 000 reports for Drug Development

Download Unlimited Documents from Trusted Public Sources

Covance Incorporated - Annual Report, 2014

  • January 2014
    128 pages
  • Credit  

  • United States  

View report >

Company Report, 2014

January 2014

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.